Literature DB >> 26902342

Prostate cancer: Increased dementia risk following androgen deprivation therapy?

Ralph N Martins1, Sam Gandy2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26902342     DOI： 10.1038/nrurol.2016.34

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  8 in total

1.  Chemical andropause and amyloid-beta peptide.

Authors:  S Gandy; O P Almeida; J Fonte; D Lim; A Waterrus; N Spry; L Flicker; R N Martins
Journal:  JAMA       Date:  2001-05-02       Impact factor: 56.272

Review 2.  Androgens in the etiology of Alzheimer's disease in aging men and possible therapeutic interventions.

Authors:  Stephanie J Fuller; Robert S Tan; Ralph N Martins
Journal:  J Alzheimers Dis       Date:  2007-09       Impact factor: 4.472

3.  Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate Cancer.

Authors:  Dawn L Hershman; Joseph M Unger; Jason D Wright; Scott Ramsey; Cathee Till; Catherine M Tangen; William E Barlow; Charles Blanke; Ian M Thompson; Maha Hussain
Journal:  JAMA Oncol       Date:  2016-04       Impact factor: 31.777

Review 4.  The impact of luteinizing hormone and testosterone on beta amyloid (Aβ) accumulation: Animal and human clinical studies.

Authors:  Giuseppe Verdile; Prita R Asih; Anna M Barron; Eka J Wahjoepramono; Lars M Ittner; Ralph N Martins
Journal:  Horm Behav       Date:  2015-06-27       Impact factor: 3.587

Review 5.  Low Testosterone Level and Risk of Alzheimer's Disease in the Elderly Men: a Systematic Review and Meta-Analysis.

Authors:  Wenshan Lv; Na Du; Ying Liu; Xinyi Fan; Yunyang Wang; Xiujuan Jia; Xu Hou; Bin Wang
Journal:  Mol Neurobiol       Date:  2015-07-08       Impact factor: 5.590

6.  Androgen Deprivation Therapy and Future Alzheimer's Disease Risk.

Authors:  Kevin T Nead; Greg Gaskin; Cariad Chester; Samuel Swisher-McClure; Joel T Dudley; Nicholas J Leeper; Nigam H Shah
Journal:  J Clin Oncol       Date:  2015-12-07       Impact factor: 44.544

7.  Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity.

Authors:  Clifford R Jack; Heather J Wiste; Stephen D Weigand; David S Knopman; Val Lowe; Prashanthi Vemuri; Michelle M Mielke; David T Jones; Matthew L Senjem; Jeffrey L Gunter; Brian E Gregg; Vernon S Pankratz; Ronald C Petersen
Journal:  Neurology       Date:  2013-10-16       Impact factor: 9.910

8.  The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men.

Authors:  Eka J Wahjoepramono; Prita R Asih; Vilia Aniwiyanti; Kevin Taddei; Satvinder S Dhaliwal; Stephanie J Fuller; Jonathan Foster; Malcolm Carruthers; Giuseppe Verdile; Hamid R Sohrabi; Ralph N Martins
Journal:  CNS Neurol Disord Drug Targets       Date:  2016       Impact factor: 4.388
  8 in total
  3 in total

1.  Development of a machine learning model to predict mild cognitive impairment using natural language processing in the absence of screening.

Authors:  Robert B Penfold; David S Carrell; David J Cronkite; Chester Pabiniak; Tammy Dodd; Ashley Mh Glass; Eric Johnson; Ella Thompson; H Michael Arrighi; Paul E Stang
Journal:  BMC Med Inform Decis Mak       Date:  2022-05-12       Impact factor: 3.298

2.  Salinomycin Exerts Anticancer Effects on PC-3 Cells and PC-3-Derived Cancer Stem Cells In Vitro and In Vivo.

Authors:  Yunsheng Zhang; Luogen Liu; Fang Li; Tao Wu; Hongtao Jiang; Xianxun Jiang; Xiaobo Du; Yi Wang
Journal:  Biomed Res Int       Date:  2017-06-06       Impact factor: 3.411

Review 3.  Inverse Correlation Between Alzheimer's Disease and Cancer: Short Overview.

Authors:  Agnieszka Zabłocka; Wioletta Kazana; Marta Sochocka; Bartłomiej Stańczykiewicz; Maria Janusz; Jerzy Leszek; Beata Orzechowska
Journal:  Mol Neurobiol       Date:  2021-09-14       Impact factor: 5.590
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.